NSE: VIJAYA · 17 November 2026
- Vijaya Diagnostic Centre Ltd. (VIJAYA) fell 1.35% on November 17, 2026, closing at ₹1,467.40 after trading between an intraday low of ₹1,457.00 and a high of ₹1,490.50.
- Vijaya Diagnostic Centre submitted its unaudited financial results for the quarter and half year ended September 30, 2026, to the exchange, alongside an investor presentation and media release. The filing detailed consolidated revenue and profit metrics for the period, reflecting the ongoing performance of its diagnostic network across Telangana, Andhra Pradesh, and other regions.
- Trading volume was 0.59 times the 20-day average daily volume.
Why is Vijaya Diagnostic Centre share price falling on 17 November 2026?
Vijaya Diagnostic Centre Ltd. (VIJAYA) fell 1.35% on November 17, 2026, closing at ₹1,467.40 after trading between an intraday low of ₹1,457.00 and a high of ₹1,490.50.
The broader market and sector indices showed positive momentum during the session, with the Nifty rising 0.38% and the Nifty Pharma sector benchmark gaining 0.21%. Vijaya Diagnostic's pullback today contrasts with this slight positive sector backdrop, reflecting minor profit-taking or localized consolidation following a strong recent run that included a 5.49% gain in the prior session and a 5.08% return over the past two sessions.
While no new operational or financial catalysts were released by the company today, the move follows its Q2 FY2027 financial performance reported in early November, alongside its recent expansion initiatives such as the acquisition of Arya Wellness Centre in Guwahati.
1.03 lakh shares traded by 17 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 1.75 lakh shares (0.59 times). The five-day average daily volume was 2.74 lakh shares. Separately, the NSE report for 17 November 2026 showed 38,241 shares delivered, representing 37.22% of that day’s traded volume. The same report recorded 12,566 trades.
The stock declined 1.35% on low volume of 0.59x its 20-day average, appearing as a natural consolidation or profit-taking move after posting a 5.49% gain in the prior session and a 5.08% return over the past two sessions, with no single confirmed catalyst driving today's action.
Latest Company Developments
Vijaya Diagnostic Centre submitted its unaudited financial results for the quarter and half year ended September 30, 2026, to the exchange, alongside an investor presentation and media release. The filing detailed consolidated revenue and profit metrics for the period, reflecting the ongoing performance of its diagnostic network across Telangana, Andhra Pradesh, and other regions.
Quarterly earnings reports are fundamental for evaluating the company's revenue growth, margin expansion, and overall valuation against market expectations.
The company announced the approval of a Business Transfer Agreement for the 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The transaction is subject to the fulfillment of customary conditions precedent set out in the agreement.
Inorganic expansion into new geographic markets supports the company's long-term growth strategy and scaling of its diagnostic network.
The company informed the exchange regarding the appointment of Mr. Rahul Jain as Company Secretary and Compliance Officer, effective November 03, 2026, following the resignation of the previous incumbent.
Ensures regulatory compliance and smooth corporate governance operations.
a press release dated November 03, 2026, titled "Press Release on Q2 FY2027 Results".
General Updates – Investor Presentation – 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 31.44% on 30 September 2026. This compares with 30.66% on 30 June 2026, a change of +0.78 percentage points.
The filing reported 27 MF/UTI holders.
What to Watch Next
- Execution progress and integration timeline regarding the Arya Wellness Centre acquisition in Guwahati
- Delivery percentage trends relative to the 37.22% recorded today
- Volume participation against the 20-day average volume benchmark
- Sustained performance against the Nifty Pharma sector benchmark
Other Dated Coverage
- Vijaya Diagnostic Centre Share Price Today: Why VIJAYA Is Rising 0.81% | 2 November 2026 — 2 November 2026
- Vijaya Diagnostic Centre Share Price Today: Why VIJAYA Is Falling 1.26% | 30 October 2026 — 30 October 2026
More Vijaya Diagnostic Centre news and dated analysis →
Frequently Asked Questions
What is the latest Vijaya Diagnostic Centre company news?
Vijaya Diagnostic Centre submitted its unaudited financial results for the quarter and half year ended September 30, 2026, to the exchange, alongside an investor presentation and media release. The filing detailed consolidated revenue and profit metrics for the period, reflecting the ongoing performance of its diagnostic network across Telangana, Andhra Pradesh, and other regions.
How strong was Vijaya Diagnostic Centre’s trading volume?
1.03 lakh shares traded, 0.59 times the 20-day average daily volume. The price and volume data are dated 17 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.
